| human | Q5 |
| P496 | ORCID iD | 0000-0001-5233-1221 |
| P734 | family name | Fuchs | Q1245268 |
| Fuchs | Q1245268 | ||
| Fuchs | Q1245268 | ||
| P735 | given name | Beth | Q14639649 |
| Beth | Q14639649 | ||
| P106 | occupation | researcher | Q1650915 |
| Q28548126 | A Defensin from the Model Beetle Tribolium castaneum Acts Synergistically with Telavancin and Daptomycin against Multidrug Resistant Staphylococcus aureus |
| Q35127316 | A multi-host approach for the systematic analysis of virulence factors in Cryptococcus neoformans |
| Q60143652 | A phenylthiazole derivative demonstrates efficacy on treatment of the cryptococcosis & candidiasis in animal models |
| Q38647694 | Activity of a novel protonophore against methicillin-resistant Staphylococcus aureus |
| Q90457103 | Anti-Candida albicans Activity of Thiazolylhydrazone Derivatives in Invertebrate and Murine Models |
| Q52692832 | Antibacterial Properties of Four Novel Hit Compounds from a Methicillin-Resistant Staphylococcus aureus-Caenorhabditis elegans High-Throughput Screen. |
| Q36479306 | Antibacterial properties of 3-(phenylsulfonyl)-2-pyrazinecarbonitrile |
| Q48143674 | Antifungal activity of clinical Lactobacillus strains against Candida albicans biofilms: identification of potential probiotic candidates to prevent oral candidiasis |
| Q28469125 | Antifungal chemical compounds identified using a C. elegans pathogenicity assay |
| Q47732056 | Antimicrobial activity of 1,3,4-oxadiazole derivatives against planktonic cells and biofilm of Staphylococcus aureus |
| Q58822253 | Butenafine and analogues: An expeditious synthesis and cytotoxicity and antifungal activities |
| Q33864072 | Caenorhabditis elegans-based model systems for antifungal drug discovery |
| Q40640348 | Candida parapsilosis Resistance to Fluconazole: Molecular Mechanisms and In Vivo Impact in Infected Galleria mellonella Larvae |
| Q35683105 | Competitive Interactions between C. albicans, C. glabrata and C. krusei during Biofilm Formation and Development of Experimental Candidiasis |
| Q42129565 | Concepts and principles of photodynamic therapy as an alternative antifungal discovery platform |
| Q39244556 | Correlation between Candida albicans biofilm formation and invasion of the invertebrate host Galleria mellonella |
| Q34563021 | Effect of virulence factors on the photodynamic inactivation of Cryptococcus neoformans |
| Q43087157 | Erratum to: Micafungin Elicits an Immunomodulatory Effect in Galleria mellonella and Mice |
| Q52565414 | Ex vitro composite plants: an inexpensive, rapid method for root biology. |
| Q36790678 | Galleria mellonella are Resistant to Pneumocystis murina Infection |
| Q24684708 | Galleria mellonella as a model host to study infection by the Francisella tularensis live vaccine strain |
| Q57150823 | Galleria mellonella experimental model for bat fungal pathogen Pseudogymnoascus destructans and human fungal pathogen Pseudogymnoascus pannorum |
| Q36599459 | Generation of composite plants using Agrobacterium rhizogenes |
| Q40202904 | Heterocycle Thiazole Compounds Exhibit Antifungal Activity through Increase in the Production of Reactive Oxygen Species in the Cryptococcus neoformans-Cryptococcus gattii Species Complex |
| Q47855340 | Histone acetyltransferase encoded by NGG1 is required for morphological conversion and virulence of Candida albicans |
| Q28547787 | Identification of an Antimicrobial Agent Effective against Methicillin-Resistant Staphylococcus aureus Persisters Using a Fluorescence-Based Screening Strategy |
| Q53689441 | In vivo and in vitro activity of a bis-arylidenecyclo-alkanone against fluconazole-susceptible and resistant isolates of Candida albicans. |
| Q41045120 | Innate recognition of cell wall β-glucans drives invariant natural killer T cell responses against fungi |
| Q35076900 | Insect-derived cecropins display activity against Acinetobacter baumannii in a whole-animal high-throughput Caenorhabditis elegans model |
| Q50060258 | Lactobacillus paracasei 28.4 reduces in vitro hyphae formation of Candida albicans and prevents the filamentation in an experimental model of Caenorhabditis elegans |
| Q36299538 | Lactobacillus paracasei modulates the immune system of Galleria mellonella and protects against Candida albicans infection |
| Q42018667 | Methods for using Galleria mellonella as a model host to study fungal pathogenesis |
| Q36365889 | Micafungin Elicits an Immunomodulatory Effect in Galleria mellonella and Mice |
| Q34057660 | Molecular and nonmolecular diagnostic methods for invasive fungal infections |
| Q30795809 | NH125 kills methicillin-resistant Staphylococcus aureus persisters by lipid bilayer disruption |
| Q38199057 | Nonmammalian model systems to investigate fungal biofilms |
| Q34067285 | Oral Candida albicans isolates from HIV-positive individuals have similar in vitro biofilm-forming ability and pathogenicity as invasive Candida isolates |
| Q37410110 | Our paths might cross: the role of the fungal cell wall integrity pathway in stress response and cross talk with other stress response pathways |
| Q58795146 | Pathogenesis of the Candida parapsilosis Complex in the Model Host Caenorhabditis elegans |
| Q37987893 | Polymerase chain reaction-based assays for the diagnosis of invasive fungal infections |
| Q100296210 | Probiotic Effects of Lactobacillus paracasei 28.4 to Inhibit Streptococcus mutans in a Gellan-Based Formulation |
| Q33369708 | Prokaryote-eukaryote interactions identified by using Caenorhabditis elegans |
| Q38819114 | Raf-kinase inhibitor GW5074 shows antibacterial activity against methicillin-resistant Staphylococcus aureus and potentiates the activity of gentamicin |
| Q40226784 | Repurposing niclosamide as a versatile antimicrobial surface coating against device-associated, hospital-acquired bacterial infections |
| Q28546591 | Repurposing salicylanilide anthelmintic drugs to combat drug resistant Staphylococcus aureus |
| Q33905903 | Role of filamentation in Galleria mellonella killing by Candida albicans |
| Q34154456 | Selecting an invertebrate model host for the study of fungal pathogenesis |
| Q52640792 | Strategies against methicillin-resistant Staphylococcus aureus persisters. |
| Q42433039 | Susceptibility of Cryptococcus neoformans to photodynamic inactivation is associated with cell wall integrity |
| Q40220923 | Synergistic Efficacy of Aedes aegypti Antimicrobial Peptide Cecropin A2 and Tetracycline against Pseudomonas aeruginosa |
| Q35147589 | The role of Candida albicans SPT20 in filamentation, biofilm formation and pathogenesis |
| Q37139366 | The role of mycelium production and a MAPK-mediated immune response in the C. elegans-Fusarium model system |
| Q40059549 | The salivary microbiome is consistent between subjects and resistant to impacts of short-term hospitalization |
| Q33281756 | The temperature-sensitive role of Cryptococcus neoformans ROM2 in cell morphogenesis |
| Q36524854 | Using non-mammalian hosts to study fungal virulence and host defense |
| Q57471032 | Vulnerability of long-term care facility residents to Clostridium difficile infection due to microbiome disruptions |
| Q28539903 | Whole animal automated platform for drug discovery against multi-drug resistant Staphylococcus aureus |
Search more.